We are live on ! Find out more
OM icon

Outset Medical

2.91 USD
-0.13
4.28%
At close Updated Nov 19, 4:00 PM EST
Pre-market
After hours
2.95
+0.04
1.37%
1 day
-4.28%
5 days
-24.42%
1 month
-23.42%
3 months
-32.33%
6 months
-24.61%
Year to date
-21.35%
1 year
-36.32%
5 years
-99.61%
10 years
-99.68%
 

About: Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Employees: 310

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 14.3%
Neutral 71.4%
Negative 14.3%
Positive
Zacks Investment Research
7 days ago
All You Need to Know About Outset Medical (OM) Rating Upgrade to Buy
Outset Medical (OM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Outset Medical (OM) Rating Upgrade to Buy
Neutral
Seeking Alpha
14 days ago
Outset Medical, Inc. (OM) Q3 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q3 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q3 2026 Earnings Call Transcript
Neutral
MarketBeat
14 days ago
Outset Medical Q3 Earnings Call Highlights
Outset Medical NASDAQ: OM reported third-quarter 2026 revenue of $33.6 million, up 14% from a year earlier, as sales of its Tablo dialysis consoles increased and recurring revenue grew. The company reiterated its full-year revenue guidance of $125 million to $130 million.
Outset Medical Q3 Earnings Call Highlights
Negative
Zacks Investment Research
14 days ago
Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.68 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $0.69 per share a year ago.
Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
15 days ago
Outset Medical Reports Third Quarter 2026 Results
SAN JOSE, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the third quarter ended September 30, 2026.
Outset Medical Reports Third Quarter 2026 Results
Neutral
GlobeNewsWire
23 days ago
Outset Medical to Participate in the 2026 Stifel Healthcare Conference
SAN JOSE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will participate in a fireside chat at the 2026 Stifel Healthcare conference on Tuesday, November 10, 2026, at 1:20 p.m.
Outset Medical to Participate in the 2026 Stifel Healthcare Conference
Neutral
GlobeNewsWire
29 days ago
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
SAN JOSE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2026 after the close of trading on Wednesday, November 4, 2026.
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Positive
Zacks Investment Research
3 months ago
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Neutral
Seeking Alpha
3 months ago
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript
Positive
MarketBeat
3 months ago
Outset Medical Q2 Earnings Call Highlights
Outset Medical NASDAQ: OM reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare.
Outset Medical Q2 Earnings Call Highlights
Price charts implemented using Lightweight Charts™